Interaction of St John's wort with low‐dose oral contraceptive therapy: a randomized controlled trial

• Published in: British journal of clinical pharmacology Vol. 56; no. 6; pp. 683 - 690
• Main Authors: Pfrunder, Arabelle, Schiesser, Monika, Gerber, Simone, Haschke, Manuel, Bitzer, Johannes, Drewe, Juergen
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Science Ltd 01.12.2003; Blackwell Science; Blackwell Science Inc
• Subjects: Adult; Biological and medical sciences; Contraceptives, Oral - pharmacokinetics; Contraceptives, Oral, Synthetic - pharmacokinetics; cytochromes; Desogestrel - pharmacokinetics; drug effects; Drug Interactions; Estrogens - pharmacokinetics; Ethinyl Estradiol - pharmacokinetics; Female; Genital system. Reproduction; Humans; Hypericum - adverse effects; interaction; Medical sciences; oral contraceptives; Ovary - drug effects; pharmacokinetics; Pharmacology. Drug treatments; Phytotherapy - methods; Plant Extracts - pharmacology; P‐glycoprotein; St John's wort; Uterine Hemorrhage - etiology; Antineoplastic agent; Ethinylestradiol; Hypericum perforatum; oral contraceptives; Desogestrel; Guttiferae; Estrogen; Extract; Progestagen; Dicotyledones; Angiospermae; Antidepressant agent; Female; Drug interaction; Human; Drug combination; Low dose; Oral administration; drug effects; Contraception; St John's wort; cytochromes; P-glycoprotein; interaction; Spermatophyta; Contraceptive; Pharmacokinetics
• ISSN: 0306-5251; 1365-2125
• DOI: 10.1046/j.1365-2125.2003.02005.x

Aims  Breakthrough bleeding or even unwanted pregnancies have been reported in women during concomitant  therapy with oral contraceptives and St  John's wort extract. The aim of the present study was to investigate the effects of St John's wort extract on oral contraceptive therapy with respect to ovarian activity, breakthrough bleeding episodes and the pharmacokinetics of ethinyloestradiol and 3‐ketodesogestrel. Methods  Eighteen healthy females were treated with a low‐dose oral contraceptive (0.02 mg ethinyloestradiol, 0.150 mg desogestrel) alone (control cycle) or combined with 300 mg St John's wort extract given twice daily (cycle A) or three times daily (cycle B). Ovarian activity was assessed by measuring follicle maturation and serum oestradiol and progesterone concentrations. The number of breakthrough bleeding episodes and the pharmacokinetics of ethinyloestradiol and 3‐ketodesogestrel were assessed under steady‐state conditions. Results  During concomitant administration of low‐dose oral contraceptive and St John's wort, there was no significant change in follicle maturation, serum oestradiol or progesterone concentrations when compared with oral contraceptive treatment alone. However, significantly more subjects reported intracyclic bleeding during cycles A (13/17 (77%), P < 0.015) and cycle B (15/17 (88%), P < 0.001) than with oral contraceptives alone (6/17 (35%)). The AUC(0,24 h) and Cmax of ethinyloestradiol remained unchanged during all study cycles, whereas the AUC(0,24 h) and Cmax of 3‐ketodesogestrel decreased significantly from 31.2 ng ml−1 h to 17.7 ng ml−1 h (43.9%; 95% confidence interval (CI) −49.3, −38.5, P = 0.001) and from 3.6 ng ml −1 to 3.0 ng ml −1(17.8%; CI −29.9, −5.7, P = 0.005), respectively, during cycle A and by 41.7% (CI −47.9, −35.6; P = 0.001) and by 22.8% (CI −31.2, −13.3; P < 0.001) during cycle B respectively, compared with the control cycle. Conclusions  There was no evidence of ovulation during low‐dose oral contraceptive and St John's wort extract combination therapy, but intracyclic bleeding episodes increased. Bleeding irregularities may adversely effect compliance to oral contraceptives and together with St John's wort‐induced decreases in serum 3‐ketodesogestrel concentrations, enhance the risk of unintended pregnancies.